# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031256
Filing Date
2022-11-10
Accepted
2022-11-10 09:20:34
Documents
69
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 910603
2 |  | ex31-1.htm | EX-31.1 | 11425
3 |  | ex31-2.htm | EX-31.2 | 10753
4 |  | ex32-1.htm | EX-32.1 | 4545
| Complete submission text file | 0001493152-22-031256.txt |  | 4251370

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | pulm-20220930.xsd | EX-101.SCH | 37639
6 | XBRL CALCULATION FILE | pulm-20220930_cal.xml | EX-101.CAL | 52760
7 | XBRL DEFINITION FILE | pulm-20220930_def.xml | EX-101.DEF | 133870
8 | XBRL LABEL FILE | pulm-20220930_lab.xml | EX-101.LAB | 302421
9 | XBRL PRESENTATION FILE | pulm-20220930_pre.xml | EX-101.PRE | 229146
63 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 577574

Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 221375296
SIC: 2834 Pharmaceutical Preparations